Skip to content

Released Feb 24, 2020, after the close

10-K filed Feb 24, 2020, 55 days after period end · 0001564590-20-006037

Q4 2019 · 10-K
Revenue$121.49M+0.3% vs Q4 2018+7.0% vs Q3 2019
Net Income$11.69M+31.7% vs Q4 2018N/M vs Q3 2019
EPS Diluted$0.60+30.4% vs Q4 2018N/M vs Q3 2019
Gross Profit$95,303,000−0.2%
Operating Income$4,095,000−67.0%
Operating Cash Flowderived$11,943,000−43.4%
Free Cash Flowderived$6,683,000−60.9%
Margins · derived
Gross margin78.4%−0.4 pt vs Q4 2018
Operating margin3.4%−6.9 pt vs Q4 2018
Net margin9.6%+2.3 pt vs Q4 2018

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2019Q4 2018Q4 2017Q4 2016
Revenue$121.49M$121.08M$116.90M$108.54M
Net Income$11.69M$8.87M$1.57M-$3.24M
EPS Diluted$0.60$0.46$0.08-$0.18

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR